These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6377501)
41. Treosulfan, cyclophosphamide and antithymocyte globulin for allogeneic hematopoietic cell transplantation in acquired severe aplastic anemia. Giebel S; Wojnar J; Krawczyk-Kulis M; Markiewicz M; Wylezoł I; Seweryn M; Holowiecka-Goral A; Holowiecki J Ann Transplant; 2006; 11(2):23-7; discussion 32-43. PubMed ID: 17494286 [TBL] [Abstract][Full Text] [Related]
42. Postoperative bone marrow infusions with cyclosporine, silica, and antilymphocyte serum in rat islet allografts. Barneo L; Field MJ; Esteban MM Transplant Proc; 1990 Apr; 22(2):859-60. PubMed ID: 2158178 [No Abstract] [Full Text] [Related]
43. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M; Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656 [TBL] [Abstract][Full Text] [Related]
44. Immunology of experimental transplantation in prite animals. Balner H Ann N Y Acad Sci; 1969 Jul; 162(1):437-52. PubMed ID: 4979564 [No Abstract] [Full Text] [Related]
45. [Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia]. Zwaan FE; Haak HL; van der Meer CW; Guiot HF; Hartgrink-Groeneveld CA; den Ottolander GJ; Willemze R; Eernisse JG; Brand A; van Rood JJ; Kunst MW; te Velde J; Noordwijk EM Ned Tijdschr Geneeskd; 1978 Mar; 122(10):326-32. PubMed ID: 24811 [No Abstract] [Full Text] [Related]
46. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma. Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994 [No Abstract] [Full Text] [Related]
47. Immunosuppressive treatment of aplastic anemia as an alternative treatment for bone marrow transplantation. Gluckman E; Marmont A; Speck B; Gordon-Smith EC Semin Hematol; 1984 Jan; 21(1):11-9. PubMed ID: 6367052 [No Abstract] [Full Text] [Related]
48. Preparation for bone marrow transplantation. Parkman R Springer Semin Immunopathol; 1984; 7(1):59-67. PubMed ID: 6377541 [No Abstract] [Full Text] [Related]
49. Bone marrow grafts and histocompatibility. Amiel JL; Schwarzenberg L; Mathé G Transplant Proc; 1971 Jun; 3(2):1072-7. PubMed ID: 4400010 [No Abstract] [Full Text] [Related]
50. Allogenic bone marrow transplantation: current status and future directions. O'Reilly RJ Blood; 1983 Nov; 62(5):941-64. PubMed ID: 6354307 [No Abstract] [Full Text] [Related]
51. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia. Wachowiak J; Bettoni C; Lange A; Malicki J; Kaczmarek-Kanold M; Głuszak B; Suchnicki K; Daszkiewicz P; Ebell W Acta Haematol Pol; 1995; 26(4):377-84. PubMed ID: 8571739 [TBL] [Abstract][Full Text] [Related]
52. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation. McGlave P; Arthur D; Haake R; Hurd D; Miller W; Vercellotti G; Weisdorf D; Kim T; Ramsay N; Kersey J J Clin Oncol; 1987 Jul; 5(7):1033-40. PubMed ID: 3298558 [TBL] [Abstract][Full Text] [Related]
53. Canine models of bone marrow transplantation. Ladiges WC; Storb R; Thomas ED Lab Anim Sci; 1990 Jan; 40(1):11-5. PubMed ID: 2153851 [TBL] [Abstract][Full Text] [Related]
54. Bone marrow transplantation for thalassaemia: Westminster Children's Hospital and United Kingdom experience. Hugh-Jones K; Vellodi A; Jones ST; Hobbs JR; Rogers JR; Abdul-Ahad A Prog Clin Biol Res; 1989; 309():201-5. PubMed ID: 2675087 [No Abstract] [Full Text] [Related]
55. Cyclosporin a: a new era in organ transplantation. DeBakey ME Compr Ther; 1984 Feb; 10(2):7-15. PubMed ID: 6368108 [No Abstract] [Full Text] [Related]
56. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients. Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487 [TBL] [Abstract][Full Text] [Related]
57. Use of donors sharing one genetic haplotype for bone marrow transplantation. Hobbs JR; Williamson S; Chambers JD; James DC; Joshi R; Shaw P; Hugh-Jones K Tokai J Exp Clin Med; 1985 Jun; 10(2-3):207-14. PubMed ID: 3914743 [TBL] [Abstract][Full Text] [Related]
58. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin. Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498 [TBL] [Abstract][Full Text] [Related]
59. Total lymphoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow. Soiffer RJ; Mauch P; Tarbell NJ; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Murrey CI; Coral F; Bosserman L Bone Marrow Transplant; 1991 Jan; 7(1):23-33. PubMed ID: 2043874 [TBL] [Abstract][Full Text] [Related]
60. The impact of Cyclosporin A on transplantation. Morris PJ Adv Surg; 1984; 17():99-127. PubMed ID: 6367397 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]